Cetuximab for the treatment of colorectal cancer

Authors :: Jonker, Derek J.
O'Callaghan, Chris J.
Karapetis, Christos S.
Zalcberg, John R.
Tu, Dongsheng
Au, Heather-Jane
Berry, Scott R.
Krahn, Marianne
Price, Timothy
Simes, R. John
Tebbutt, Niall C.
van Hazel, Guy
Wierzbicki, Rafal
Langer, Christiane
Moore, Malcolm J.
Source :: The New England Journal of Medicine. Nov 15, 2007, Vol. 357 Issue 20, p2040, 9 p.
Publication Year :: 2007
Abstract: The trial results for the treatment of colorectal cancer with cetuximab, a chimeric monoclonal antibody against the epidermal growth factor receptor (EGFR) is reported. The overall survival and progression-free survival were found to be better among patients receiving cetuximab in whom other treatments failed.